Short interest for Serina Therapeutics gives investors a sense of the degree to which investors are betting on the decline of Serina Therapeutics's stock. Short interest data is updated every two weeks.

Serina Therapeutics Stock (AMEX:SER), Short Interest Report

Serina Therapeutics

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics Inc

Sera Prognostics, Inc. - Class A Common Stock

Sera Prognostics Inc

Serko Ltd

Seiren Co Ltd

Super Zero Protocol

Serve Robotics Inc

Allison Ventures, Allison Transmission's venture capital arm, is pleased to announce it has committed to a $10 million investment in EnerTech Capital, a venture capital firm focused on the development of emerging technologies and business models in the mobility space.
Through this partnership, Allison will gain access to EnerTech's large network of high-tech companies that are advancing automotive technologies in the electrification, connectivity, autonomy and digitization sectors.

News

Contracts

ALSN

Allison Transmission Invests $10M In EnerTech Capital, To Focus On The Development Of Emerging Technologies And Business Models In The Mobility Space.

As part of Northern Waters&#39; sportsbook enhancements, the&nbsp;casino&nbsp;plans to deploy IGT&#39;s PeakBarTop&nbsp;cabinets with Total Gaming&nbsp;software.

IGT PlaySports Unveils Trading Advisory Services In Michigan With Lac Vieux Desert Northern Waters Casino & Resort

The Baldwin Group, the go-to-market brand name for The Baldwin Insurance Group, Inc. (formerly BRP Group, Inc.) ("Baldwin" or the "Company") (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BRP#NASDAQ">BRP</a>), highlighted today that its Class A common stock will begin trading on NASDAQ under the new ticker symbol "BWIN" as of market open on May 20, 2024. This will replace the Company's current ticker symbol "BRP".
The new ticker symbol "BWIN" aligns with the Company's rebranding to The Baldwin Group and related name change, previously announced on May 1, 2024.

The Baldwin Group Ticker Symbol To Change To 'BWIN' On May 20, 2024

<h3>Gainers</h3>
<ul>
<li>Golden Sun Health (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GSUN#NASDAQ">GSUN</a>) stock moved upwards by 8.7% to $4.98 during Thursday's after-market session. The company's market cap stands at $9.5 million. </li>
<li>Despegar.com (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DESP#NYSE">DESP</a>) shares increased by 8.45% to $13.6. The company's market cap stands at $979.9 million. As per the press release, Q1 earnings came out today. </li>
<li>Cheetah Net Supply Chain (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTNT#NASDAQ">CTNT</a>) stock increased by 7.99% to $8.1. The company's market cap stands at $155.4 million. As per the news, the Q1 earnings report came out 3 days ago. </li>
<li>Worksport (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKSP#NASDAQ">WKSP</a>) shares increased by 7.57% to $0.67. The market value of their outstanding shares is at $16.1 million. As per the news, the Q1 earnings report came out today. </li>
<li>Selina Hospitality (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLNA#NASDAQ">SLNA</a>) shares increased by 6.46% to $0.14. The company's market cap stands at $77.8 million. </li>
<li>MGO Global (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MGOL#NASDAQ">MGOL</a>) stock rose 5.72% to $0.25. The market value of their outstanding shares is at $4.1 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Cracker Barrel Old (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBRL#NASDAQ">CBRL</a>) shares fell 9.2% to $52.0 during Thursday's after-market session. The market value of their outstanding shares is at $1.1 billion. </li>
<li>Greenlane Hldgs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares decreased by 8.32% to $0.56. The market value of their outstanding shares is at $2.0 million. </li>
<li>Phoenix Motor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEV#NASDAQ">PEV</a>) shares decreased by 6.55% to $0.42. The market value of their outstanding shares is at $14.4 million. </li>
<li>Jeffs Brands (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFBR#NASDAQ">JFBR</a>) shares declined by 5.49% to $0.29. The company's market cap stands at $1.7 million. </li>
<li>Connexa Sports Techs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/YYAI#NASDAQ">YYAI</a>) stock decreased by 4.0% to $0.8. The market value of their outstanding shares is at $28.0 million. </li>
<li>EZGO Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EZGO#NASDAQ">EZGO</a>) stock fell 3.73% to $1.81. The company's market cap stands at $4.6 million. 
See Also: <a href="http://www.benzinga.com/money/best-consumer-cyclical-stocks/" title="www.benzinga.com/money/best-consumer-cyclical-stocks/">www.benzinga.com/money/best-consumer-cyclical-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Movers

CBRL

CTNT

DESP

EZGO

GNLN

GSUN

JFBR

MGOL

SLNA

WKSP

Connexa Sports Technologies Inc. - Common Stock

YYAI

12 Consumer Discretionary Stocks Moving In Thursday's After-Market Session

PNTG

Pennant Acquires Nurses On Wheels; Financial Terms Not Disclosed

<h3>Gainers</h3>
<ul>
<li>Scorpius Holdings (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SCPX#AMEX">SCPX</a>) shares rose 20.9% to $0.12 during Thursday's after-market session. The market value of their outstanding shares is at $4.3 million. </li>
<li>Kintara Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KTRA#NASDAQ">KTRA</a>) stock increased by 19.22% to $0.17. The company's market cap stands at $6.7 million. The company's, Q3 earnings came out 2 days ago. </li>
<li>Doximity (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DOCS#NYSE">DOCS</a>) stock rose 11.4% to $26.45. The market value of their outstanding shares is at $4.9 billion. As per the news, the Q4 earnings report came out today. </li>
<li>MEI Pharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEIP#NASDAQ">MEIP</a>) stock increased by 10.92% to $3.25. The company's market cap stands at $21.6 million. </li>
<li>Akso Health Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHG#NASDAQ">AHG</a>) stock increased by 9.36% to $0.69. The company's market cap stands at $101.0 million. </li>
<li>Onconetix (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ONCO#NASDAQ">ONCO</a>) shares increased by 7.73% to $0.15. The company's market cap stands at $3.3 million. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>TFF Pharmaceuticals (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TFFP#NASDAQ">TFFP</a>) stock decreased by 11.5% to $2.0 during Thursday's after-market session. The company's market cap stands at $6.1 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>OptiNose (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPTN#NASDAQ">OPTN</a>) stock decreased by 9.24% to $1.18. The market value of their outstanding shares is at $133.3 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Turnstone Biologics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TSBX#NASDAQ">TSBX</a>) stock fell 6.23% to $2.56. The market value of their outstanding shares is at $59.2 million. The company's, Q1 earnings came out 3 days ago. </li>
<li>Intelligent Bio Solutions (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INBS#NASDAQ">INBS</a>) stock decreased by 5.54% to $2.22. The company's market cap stands at $6.9 million. </li>
<li>Lucy Scientific Discovery (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LSDI#NASDAQ">LSDI</a>) shares fell 5.04% to $1.51. The company's market cap stands at $2.6 million. </li>
<li>BioSig Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BSGM#NASDAQ">BSGM</a>) shares fell 4.97% to $1.53. The market value of their outstanding shares is at $18.3 million. 
See Also: <a href="http://www.benzinga.com/money/best-healthcare-stocks/" title="www.benzinga.com/money/best-healthcare-stocks/">www.benzinga.com/money/best-healthcare-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

BSGM

DOCS

Intelligent Bio Solutions Inc. - Common Stock

INBS

Kintara Therapeutics, Inc. - Common Stock

KTRA

LSDI

MEIP

ONCO

OPTN

SCPX

TFFP

TSBX

12 Health Care Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Pineapple Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PEGY#NASDAQ">PEGY</a>) stock moved upwards by 10.1% to $0.16 during Thursday's after-market session. The market value of their outstanding shares is at $14.6 million. </li>
<li>Greenwave Tech Solns (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GWAV#NASDAQ">GWAV</a>) stock rose 7.42% to $0.16. The market value of their outstanding shares is at $23.9 million. </li>
<li>Azul (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AZUL#NYSE">AZUL</a>) shares moved upwards by 4.91% to $6.19. The company's market cap stands at $716.7 million. As per the press release, Q1 earnings came out 3 days ago. </li>
<li>Safe &amp; Green Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGBX#NASDAQ">SGBX</a>) stock moved upwards by 4.85% to $3.89. The company's market cap stands at $4.7 million. </li>
<li>Ideanomics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IDEX#NASDAQ">IDEX</a>) stock increased by 4.76% to $1.1. The company's market cap stands at $13.1 million. </li>
<li>Hydrofarm Holdings Group (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HYFM#NASDAQ">HYFM</a>) stock rose 4.65% to $0.9. The market value of their outstanding shares is at $41.3 million. The company's, Q1 earnings came out 2 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>Exela Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) shares declined by 7.6% to $2.43 during Thursday's after-market session. The market value of their outstanding shares is at $15.4 million. As per the press release, Q1 earnings came out yesterday. </li>
<li>CBAK Energy Tech (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CBAT#NASDAQ">CBAT</a>) stock decreased by 3.04% to $1.28. The company's market cap stands at $115.0 million. As per the news, the Q1 earnings report came out 4 days ago. </li>
<li>Fusion Fuel Green (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/HTOO#NASDAQ">HTOO</a>) stock fell 2.44% to $1.2. The company's market cap stands at $20.8 million. </li>
<li>Polar Power (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/POLA#NASDAQ">POLA</a>) stock declined by 2.25% to $0.49. The company's market cap stands at $8.5 million. </li>
<li>Fiverr Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FVRR#NYSE">FVRR</a>) stock fell 2.19% to $24.55. The market value of their outstanding shares is at $950.1 million. </li>
<li>OceanPal (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OP#NASDAQ">OP</a>) shares declined by 2.03% to $2.42. The company's market cap stands at $18.0 million. 
See Also: <a href="http://www.benzinga.com/money/best-industrials-stocks/" title="www.benzinga.com/money/best-industrials-stocks/">www.benzinga.com/money/best-industrials-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AZUL

CBAT

FVRR

GWAV

HTOO

HYFM

IDEX

PEGY

POLA

SGBX

XELA

12 Industrials Stocks Moving In Thursday's After-Market Session

<h3>Gainers</h3>
<ul>
<li>Cyngn (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CYN#NASDAQ">CYN</a>) stock rose 14.2% to $0.15 during Thursday's after-market session. The company's market cap stands at $15.8 million. </li>
<li>Strong Global (AMEX:<a class="ticker" href="https://www.benzinga.com/stock/SGE#AMEX">SGE</a>) stock increased by 9.48% to $1.5. The company's market cap stands at $11.8 million. As per the press release, Q1 earnings came out 2 days ago. </li>
<li>WaveDancer (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WAVD#NASDAQ">WAVD</a>) shares rose 9.27% to $3.18. The market value of their outstanding shares is at $6.4 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Cemtrex (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETX#NASDAQ">CETX</a>) stock increased by 8.69% to $0.35. The company's, Q2 earnings came out 2 days ago. </li>
<li>LivePerson (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LPSN#NASDAQ">LPSN</a>) stock moved upwards by 8.16% to $0.78. The company's market cap stands at $69.1 million. </li>
<li>Akoustis Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AKTS#NASDAQ">AKTS</a>) stock rose 5.55% to $0.42. The market value of their outstanding shares is at $41.4 million. As per the press release, Q3 earnings came out 3 days ago. </li>
</ul>
<h3>Losers</h3>
<ul>
<li>DXC Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DXC#NYSE">DXC</a>) stock fell 20.3% to $15.84 during Thursday's after-market session. The company's market cap stands at $2.8 billion. As per the news, the Q4 earnings report came out today. </li>
<li>Brand Engagement Network (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BNAI#NASDAQ">BNAI</a>) shares declined by 11.82% to $1.12. The company's market cap stands at $37.3 million. The company's, Q1 earnings came out 2 days ago. </li>
<li>Ascent Solar Technologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ASTI#NASDAQ">ASTI</a>) stock declined by 8.14% to $0.16. The market value of their outstanding shares is at $4.8 million. </li>
<li>Globant (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOB#NYSE">GLOB</a>) stock declined by 7.17% to $165.0. The market value of their outstanding shares is at $7.1 billion. The company's, Q1 earnings came out today. </li>
<li>X3 Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XTKG#NASDAQ">XTKG</a>) stock decreased by 6.27% to $0.73. The market value of their outstanding shares is at $200.0 million. </li>
<li>Auddia (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AUUD#NASDAQ">AUUD</a>) stock decreased by 3.45% to $1.4. The company's market cap stands at $3.3 million. As per the press release, Q1 earnings came out 2 days ago. 
See Also: <a href="http://www.benzinga.com/money/tech-stocks/" title="www.benzinga.com/money/tech-stocks/">www.benzinga.com/money/tech-stocks/</a></li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

AKTS

ASTI

AUUD

BNAI

CETX

GLOB

LPSN

WAVD

XTKG

12 Information Technology Stocks Moving In Thursday's After-Market Session

Myriad's Prolaris Test is the only biomarker test to quantify the benefits of adding androgen deprivation therapy to radiation therapy1
SALT LAKE CITY, May 16, 2024 (GLOBE NEWSWIRE) -- <a href="https://www.globenewswire.com/Tracker?data=SMESdDe-tLSPEmBojpAqz-dukwYQg6OwfI-0EzLw8k0mjDFVssI_4VV5qH3XlEtTIQjhUulw6yaBdalMi4_zMA==">Myriad Genetics, Inc</a>. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MYGN#NASDAQ">MYGN</a>), a leader in genetic testing and precision medicine, announced that JCO Precision Oncology has published a <a href="https://www.globenewswire.com/Tracker?data=Y62Hv25zi5pmQ_hIIRAFbUYPB3tJJBARrHg2X6igl7fQSenZFX9LNtXlrNKF4enpzWHSoZtYBxGiqOhK2tTaT6U8wekQdTz97YQLU4_EFE8=">study</a> showing a clinical cell-cycle risk (CCR) score can accurately predict the benefit of adding androgen deprivation therapy (ADT) to radiation therapy (RT) in men with localized prostate cancer.
Guidelines currently recommend adding ADT to RT in certain patients with localized prostate cancer. While ADT can be effective at slowing the progression of prostate cancer, it can also be associated with significant side effects, such as bone and muscle loss, weight gain, and increased cardiovascular risk.
The study – first presented as a poster at the 2023 American Society of Clinical Oncology (ASCO) Annual Conference by Dr. Jonathan Tward – examined two cohorts of male patients tested with the Prolaris&#xAE;&nbsp;Prostate Cancer Prognostic Test either clinically or through retrospective studies.

Biotech

General

MYGN

Myriad Genetics Study Published In JCO Precision Oncology Shows Co's Prolaris Test Can Predict Benefit Of Hormone Therapy Treatment In Men With Localized Prostate Cancer

Novo Nordisk (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVO#NYSE">NVO</a>) has outperformed the market over the past 10 years by 9.23% on an annualized basis producing an average annual return of 20.06%. Currently, Novo Nordisk has a market capitalization of $592.67 billion. 
Buying $1000 In NVO: If an investor had bought $1000 of NVO stock 10 years ago, it would be worth $6,279.92 today based on a price of $133.04 for NVO at the time of writing.
<h3>Novo Nordisk's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715891420_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

Here's How Much You Would Have Made Owning Novo Nordisk Stock In The Last 10 Years

WIIM

TTWO

Take-Two Interactive Software shares are trading lower after the company reported Q4 earnings and issued FY25 guidance. The company also narrowed its GTA VI release window to fall of 2025.

Quanta Services (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PWR#NYSE">PWR</a>) has outperformed the market over the past 10 years by 12.38% on an annualized basis producing an average annual return of 23.2%. Currently, Quanta Services has a market capitalization of $38.62 billion. 
Buying $1000 In PWR: If an investor had bought $1000 of PWR stock 10 years ago, it would be worth $8,092.64 today based on a price of $263.82 for PWR at the time of writing.
<h3>Quanta Services's Performance Over Last 10 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2024/1715891415_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

If You Invested $1000 In This Stock 10 Years Ago, You Would Have $8,100 Today

<h3>GAINERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/FLOOF">Flower One Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FLOOF#OTC">FLOOF</a>) shares closed up 900.00% at $1e-05</li>
<li><a href="https://www.benzinga.com/quote/BLOZF">Cannabix Technologies</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLOZF#OTC">BLOZF</a>) shares closed up 28.41% at $0.60</li>
<li><a href="https://www.benzinga.com/quote/GNLN">Greenlane Hldgs</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GNLN#NASDAQ">GNLN</a>) shares closed up 16.06% at $0.61</li>
<li><a href="https://www.benzinga.com/quote/CNBX">CNBX Pharmaceuticals</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNBX#OTC">CNBX</a>) shares closed up 14.29% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/FFNTF">4Front Ventures</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FFNTF#OTC">FFNTF</a>) shares closed up 13.03% at $0.13</li>
<li><a href="https://www.benzinga.com/quote/UGRO">Urban-gro</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UGRO#NASDAQ">UGRO</a>) shares closed up 12.58% at $1.75</li>
<li><a href="https://www.benzinga.com/quote/LMLLF">Pharmadrug</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LMLLF#OTC">LMLLF</a>) shares closed up 12.00% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/RMHB">Rocky Mountain High</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RMHB#OTC">RMHB</a>) shares closed up 11.67% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CGC">Canopy Gwth</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CGC#NASDAQ">CGC</a>) shares closed up 10.19% at $10.99</li>
<li><a href="https://www.benzinga.com/quote/OILFF">Nextleaf Solutions</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/OILFF#OTC">OILFF</a>) shares closed up 10.18% at $0.11</li>
<li><a href="https://www.benzinga.com/quote/ACB">Aurora Cannabis</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ACB#NASDAQ">ACB</a>) shares closed up 7.16% at $7.60</li>
<li><a href="https://www.benzinga.com/quote/GRWG">GrowGeneration</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GRWG#NASDAQ">GRWG</a>) shares closed up 6.61% at $2.89</li>
<li><a href="https://www.benzinga.com/quote/EAST">Eastside Distilling</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) shares closed up 6.43% at $1.05</li>
<li><a href="https://www.benzinga.com/quote/FUAPF">Global Compliance</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/FUAPF#OTC">FUAPF</a>) shares closed up 6.28% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/CARA">Cara Therapeutics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CARA#NASDAQ">CARA</a>) shares closed up 5.96% at $0.81</li>
<li><a href="https://www.benzinga.com/quote/CNTMF">Cansortium</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNTMF#OTC">CNTMF</a>) shares closed up 5.88% at $0.18</li>
<li><a href="https://www.benzinga.com/quote/CRON">Cronos Group</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRON#NASDAQ">CRON</a>) shares closed up 5.86% at $3.02</li>
<li><a href="https://www.benzinga.com/quote/CNPOF">RIV Capital</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CNPOF#OTC">CNPOF</a>) shares closed up 5.74% at $0.10</li>
<li><a href="https://www.benzinga.com/quote/ITHUF">iAnthus Capital Hldgs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ITHUF#OTC">ITHUF</a>) shares closed up 5.34% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/BBRRF">Blueberries Medical</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BBRRF#OTC">BBRRF</a>) shares closed up 5.18% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/TCNNF">Trulieve Cannabis</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/TCNNF#OTC">TCNNF</a>) shares closed up 4.87% at $12.48</li>
<li><a href="https://www.benzinga.com/quote/ZDPY">Zoned Props</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/ZDPY#OTC">ZDPY</a>) shares closed up 4.76% at $0.66</li>
<li><a href="https://www.benzinga.com/quote/CRBP">Corbus Pharmaceuticals</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRBP#NASDAQ">CRBP</a>) shares closed up 4.03% at $45.92</li>
<li><a href="https://www.benzinga.com/quote/OGI">OrganiGram Holdings</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGI#NASDAQ">OGI</a>) shares closed up 3.63% at $2.03</li>
<li><a href="https://www.benzinga.com/quote/CBDY">Target Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBDY#OTC">CBDY</a>) shares closed up 3.51% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/SNDL">SNDL</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SNDL#NASDAQ">SNDL</a>) shares closed up 3.49% at $2.65</li>
<li><a href="https://www.benzinga.com/quote/NWVCF">EnWave</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NWVCF#OTC">NWVCF</a>) shares closed up 3.09% at $0.19</li>
</ul>
<h3>LOSERS:</h3>
<ul>
<li><a href="https://www.benzinga.com/quote/MJNE">MJ Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MJNE#OTC">MJNE</a>) shares closed down 24.29% at $0.01</li>
<li><a href="https://www.benzinga.com/quote/MGWFF">Maple Leaf Green World</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/MGWFF#OTC">MGWFF</a>) shares closed down 17.99% at $0.03</li>
<li><a href="https://www.benzinga.com/quote/RSSFF">Affinor Growers</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/RSSFF#OTC">RSSFF</a>) shares closed down 14.44% at $0.11</li>
<li><a href="https://www.benzinga.com/quote/KAYS">Kaya Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/KAYS#OTC">KAYS</a>) shares closed down 12.89% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/BLGVF">Belgravia Hartford Cap</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/BLGVF#OTC">BLGVF</a>) shares closed down 8.06% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CBWTF">Auxly Cannabis Group</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CBWTF#OTC">CBWTF</a>) shares closed down 4.59% at $0.04</li>
<li><a href="https://www.benzinga.com/quote/PMD">Psychemedics</a> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PMD#NASDAQ">PMD</a>) shares closed down 4.28% at $2.56</li>
<li><a href="https://www.benzinga.com/quote/LBUY">Leafbuyer Techs</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/LBUY#OTC">LBUY</a>) shares closed down 3.82% at $0.02</li>
<li><a href="https://www.benzinga.com/quote/CWBHF">Charlottes Web Holdings</a> (OTC:<a class="ticker" href="https://www.benzinga.com/stock/CWBHF#OTC">CWBHF</a>) shares closed down 3.79% at $0.17</li>
</ul>
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Cannabis

Markets

BBRRF

BLGVF

BLOZF

CARA

CBDY

CANNABIS WHEATON INCOME by Cannabis Wheaton Income Corp.

CBWTF

CNBX

CNPOF

CNTMF

CRBP

CRON

CWBHF

EAST

FFNTF

FLOOF

FUAPF

GRWG

ITHUF

KAYS

LEAFBUYER TECHNOLOGIES by Leafbuyer Technologies, Inc.

LBUY

LMLLF

MGWFF

MJNE

NWVCF

OILFF

RMHB

RSSFF

SNDL

TCNNF

UGRO

ZDPY

Cannabis Stock Gainers And Losers From May 16, 2024

TEN, Ltd (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TNP#NYSE">TNP</a>) (the "Company") announces that following the delivery of three vessels since the beginning of 2024, the Dual-Fuel LNG LR2 product tankers "Ithaki DF", "Chios DF" and "DF Montmartre", three more vessels have recently joined the fleet and consist of the 2023-built Dual-Fuel LNG LR2 product tanker "DF Mystras", the 2018-built scrubber fitted 1A Ice Class, Aframax "Alpes"and the 2018-built Super Eco Suezmax, "Poppy S" which was delivered on May 14, 2024. An additional seventh vessel, the 2019-built scrubber fitted 1A Ice Class, Aframax "Aspen", will be delivered by the end of May upon completion of its special survey currently performed by her present owners.
All these vessels are employed on time-charter contracts with profit-sharing provisions, with expected minimum gross revenues in excess of $200 million.
"We welcome these environmentally friendly tankers in TEN which bring us closer to our goal for a full "green" fleet by 2030. These new acquisitions increase TEN's cash generating prowess while further deepening its environmental footprint in the ever-evolving energy space," Mr. George Saroglou, President &amp; COO of TEN stated. "Our "green ship" initiative continues with eight more vessels currently under construction to join our fleet from next year," Mr. Saroglou concluded.

TEN Ltd. Delivered 6 Environmentally Friendly Vessels Since The Beginning Of 2024; Vessels Are Employed On Time-Charter Contracts With Profit-Sharing Provisions, With Expected Minimum Gross Revenues In Excess Of $200M

<a href="https://www.sec.gov/ix?doc=/Archives/edgar/data/1761918/000119312524140591/d832290d8k.htm" title="https://www.sec.gov/ix?doc=/Archives/edgar/data/1761918/000119312524140591/d832290d8k.htm">https://www.sec.gov/ix?doc=/Archives/edgar/data/1761918/000119312524140591/d832290d8k.htm</a>

ERAS

Erasca Reveals Reduction In Workforce By ~18%, In Connection With Strategic Reprioritization, Primarily Affecting Employees Working In Drug Discovery Functions Or On Deprioritized Programs - Filing

Offerings

JAMF

Jamf Holding Said On May 13, Entered Underwriting Agreement; Post Underwriting Agreement, Selling Stockholders To Sell 9M Shares Of Common Stock To Underwriters At Price Per Share Of $17.52

SHBI

Shore Bancshares Files For Mixed Shelf Offering Up To $175M

Avinger, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVGR#NASDAQ">AVGR</a>), a commercial-stage medical device company developing and marketing the first and only intravascular image-guided, catheter-based systems for diagnosis and treatment of vascular disease, today announced the conversion of $11 million or approximately 80% of its existing debt with entities affiliated with CRG Partners III L.P. ("CRG") into a shares of a new series of convertible preferred stock.
Following the conversion, the outstanding principal amount of debt with CRG is $2.6 million. The debt conversion results in an $11 million increase in stockholders' equity.

Financing

AVGR

Avinger Converts $11M Of CRG Debt Into Preferred Equity

Take-Two Interactive Software, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TTWO#NASDAQ">TTWO</a>) reported its fourth-quarter financial results after the bell Thursday. Here's a <a href="https://www.benzinga.com/pressreleases/24/05/b38882943/take-two-interactive-software-inc-reports-results-for-fourth-quarter-and-fiscal-year-2024">look at the details. </a>
The Details: Take-Two Interactive reported adjusted earnings of $1.21 per share and quarterly sales of $1.399 billion, beating the $1.299 billion analyst consensus estimate.
Total Net Bookings decreased 3% to $1.35 billion, as compared to $1.39 billion from the prior year&#8217;s fiscal fourth quarter.
Net Bookings from recurrent consumer spending decreased 2% and accounted for 79% of total Net Bookings. Take-Two said the largest contributors to Net Bookings were NBA 2K24, Grand Theft Auto Online and Grand Theft Auto V, Toon Blast, Empires &amp; Puzzles, its hyper-casual mobile portfolio, Red Dead Redemption 2 and Red Dead Online, WWE 2K24, Match Factory!, Words With Friends and Merge Dragons!.
&#8220;We concluded Fiscal 2024 with strong fourth-quarter results, including Net Bookings of $1.35 billion, which exceeded the high-end of our guidance range. Many of our key franchises outperformed, including NBA 2K24; Zynga&#8217;s in-app purchases, led by Toon Blast and our newest hit, Match Factory!; the Red Dead Redemption series and the Grand Theft Auto series,&#8221; said Strauss Zelnick, CEO of Take-Two.
Outlook: Take-Two sees fiscal year 2025 Net Bookings in a range of $5.55 billion to $5.65 billion. The company said the outlook reflects a narrowing of Rockstar&#8217;s previously established window to Fall of Calendar 2025 for Grand Theft Auto VI.
&#8220;We are highly confident that Rockstar Games will deliver an unparalleled entertainment experience, and our expectations for the commercial impact of the title continue to increase. Looking ahead, we believe that our Company is poised to achieve new levels of success, and we expect to deliver sequential growth in Net Bookings for Fiscal 2025, 2026, and 2027,&#8221; said Zelnick. 
TTWO Price Action: According to <a href="https://pro.benzinga.com/?gspk=YWRhbWVja2VydDUzMzY&amp;gsxid=zBMR4PKmcgBw">Benzinga Pro</a>, Take-Two Interactive Software shares are down 3.66% at $140.74 after-hours at the time of publication Thursday.
Related News: <a href="https://www.benzinga.com/news/24/05/38878911/whats-going-on-with-faraday-future-intelligent-electric-stock">What&#8217;s Going On With Faraday Future Intelligent Electric Stock?</a>
Photo: Victoria from Pixabay

Earnings

Gaming

After-Hours Center

Take-Two Interactive Shares Fall After Q4 Results, FY 2025 Outlook

CORRECTION: Take-Two Interactive Q4 Adj $0.28 Beats $0.09 Estimate, Sales $1.35B Beat $1.30B Estimate

Serina Therapeutics (SER) just unveiled an announcement. AgeX Therapeutics, Inc. has successfully completed a strategic financial restructuring thr...

Serina Therapeutics: Strategic Restructuring and Merger Success

<a href="https://investorplace.com">InvestorPlace - Stock Market News, Stock Advice &amp; Trading Tips</a>
It&rsquo;s time to check out all of the biggest pre-market stock movers worth watching on Tuesday morning!



Moving stocks this morning are merger agreements, earnings reports, and a major spinoff worth checking out.



Let&rsquo;s get into that news below!



<h2>Biggest Pre-Market Stock Movers: 10 Top Gainers</h2>



<ol><li>XTI Aerospace (NASDAQ:<a href="https://investorplace.com/stock-quotes/xtia-stock-quote/">XTIA</a>) stock is rocketing more than 94% alongside heavy pre-market trading.</li>



<li>Kidpik (NASDAQ:<a href="https://investorplace.com/stock-quotes/pik-stock-quote/">PIK</a>) shares are soaring over 65% after <a href="https://www.businesswire.com/news/home/20240401494590/en/Kidpik-and-Nina-Footwear-Announce-Entry-Into-Definitive-Merger-Agreement">announcing a merger agreement</a>.</li>



<li>MSP Recovery (NASDAQ:<a href="https://investorplace.com/stock-quotes/lifw-stock-quote/">LIFW</a>) stock is surging more than 51% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318207498&amp;type=PDF&amp;symbol=LIFW&amp;cdn=d7d2eb0036ce9fef1e4f01d2811ba3c3&amp;companyName=MSP+Recovery+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-01">amending a Master Transaction Agreement</a>.</li>



<li>Gaxos.AI (NASDAQ:<a href="https://investorplace.com/stock-quotes/gxai-stock-quote/">GXAI</a>) shares are gaining over 42% on Tuesday morning.</li>



<li>Serina Therapeutics (NYSEMKT:<a href="https://investorplace.com/stock-quotes/ser-stock-quote/">SER</a>) stock is increasing more than 28% on a <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318207540&amp;type=PDF&amp;symbol=SER&amp;cdn=5bb39acd5530c99bf9d9f33aff01c374&amp;companyName=Serina+Therapeutics+Inc.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-01">merger agreement update</a>.</li>



<li>Trio Petroleum (NYSEMKT:<a href="https://investorplace.com/stock-quotes/tpet-stock-quote/">TPET</a>) shares are rising over 20% after <a href="https://app.quotemedia.com/data/downloadFiling?webmasterId=90423&amp;ref=318207241&amp;type=PDF&amp;symbol=TPET&amp;cdn=d4589c47a98244a54b35ccc5e07d6637&amp;companyName=Trio+Petroleum+Corp.&amp;formType=8-K&amp;formDescription=Current+report+pursuant+to+Section+13+or+15%28d%29&amp;dateFiled=2024-04-01">borrowing money from its CEO</a>.</li>



<li>Zapata Computing (NASDAQ:<a href="https://investorplace.com/stock-quotes/zpta-stock-quote/">ZPTA</a>) stock is climbing more than 19% after its <a href="https://investorplace.com/2024/04/zpta-stock-7-things-to-know-as-zapata-computing-starts-trading-today/">recent public debut</a>.</li>



<li>CareMax (NASDAQ:<a href="https://investorplace.com/stock-quotes/cmax-stock-quote/">CMAX</a>) shares are heading over 18% higher without any clear news this morning.</li>



<li>HWH International (NASDAQ:<a href="https://investorplace.com/stock-quotes/hwh-stock-quote/">HWH</a>) stock is jumping more than 17% this morning.</li>



<li>VirTra (NASDAQ:<a href="https://investorplace.com/stock-quotes/vtsi-stock-quote/">VTSI</a>) shares are up over 16% on <a href="https://www.marketwatch.com/story/virtra-stock-jumps-17-after-4q-results-get-a-lift-from-streamlined-operations-36fa5579">strong Q4 earnings</a>.</li>
</ol><h2>10 Top Losers</h2>



<ol><li>Acorda Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/acor-stock-quote/">ACOR</a>) stock is plummeting more than 59% on a <a href="https://www.nasdaq.com/press-release/acorda-therapeutics-and-merz-announce-signing-of-stalking-horse-asset-purchase">stalking horse asset purchase agreement</a>.</li>



<li>Gritstone Bio (NASDAQ:<a href="https://investorplace.com/stock-quotes/grts-stock-quote/">GRTS</a>) shares are diving over 32% after <a href="https://www.nasdaq.com/press-release/gritstone-bio-announces-pricing-of-%2432.5-million-underwritten-public-offering-2024-04">pricing a public offering</a>.</li>



<li>Canoo (NASDAQ:<a href="https://investorplace.com/stock-quotes/goev-stock-quote/">GOEV</a>) stock is tumbling more than 24% with its <a href="https://finance.yahoo.com/news/canoo-inc-goev-reports-fiscal-221142649.html">latest earnings results</a>.</li>



<li>Microvast (NASDAQ:<a href="https://investorplace.com/stock-quotes/mvst-stock-quote/">MVST</a>) shares are taking an over 22% beating <a href="https://www.benzinga.com/news/earnings/24/04/38035918/microvast-q4-earnings-revenue-beat-eps-beat-gross-margin-improvement-and-more">despite beating Q4 estimates</a>.</li>



<li>PVH (NYSE:<a href="https://investorplace.com/stock-quotes/pvh-stock-quote/">PVH</a>) stock is dropping more than 22% after <a href="https://finance.yahoo.com/news/calvin-klein-owner-pvh-tumbles-214551310.html">warning of weakness in Europe</a>.</li>



<li>Avalo Therapeutics (NASDAQ:<a href="https://investorplace.com/stock-quotes/avtx-stock-quote/">AVTX</a>) shares are sliding close to 20% following its <a href="https://invezz.com/news/2024/04/01/avalo-therapeutics-avtx-stock-slips-after-earnings-buy-the-dip/">latest earnings report</a>.</li>



<li>GE Aerospace (NYSE:<a href="https://investorplace.com/stock-quotes/ge-stock-quote/">GE</a>) stock is decreasing over 19% <a href="https://www.marketwatch.com/story/ge-spins-off-ge-vernova-pivots-to-pure-play-aerospace-stock-58767b54">following its Vernova spinoff</a>.</li>



<li>IM Cannabis (NASDAQ:<a href="https://investorplace.com/stock-quotes/imcc-stock-quote/">IMCC</a>) shares are falling more than 18% on an <a href="https://www.nasdaq.com/press-release/imc-applauds-the-april-1st-implementation-of-the-new-israeli-cannabis-regulation">update to Israel&rsquo;s cannabis regulations</a>.</li>



<li>Aclarion (NASDAQ:<a href="https://investorplace.com/stock-quotes/acon-stock-quote/">ACON</a>) stock is slipping over 17% on Tuesday morning.</li>



<li>Pioneer Power Solutions (NASDAQ:<a href="https://investorplace.com/stock-quotes/ppsi-stock-quote/">PPSI</a>) shares close out our pre-market stock movers down more than 16% with its <a href="https://www.nasdaq.com/press-release/pioneer-achieves-51-year-over-year-increase-in-revenue-reaching-%2440.8-million-2024-04">most recent earnings report</a>.</li>
</ol>On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the&nbsp;InvestorPlace.com&nbsp;<a href="https://investorplace.com/corporate/investorplace-publishing-guidelines/" target="_blank">Publishing Guidelines</a>.
<h3>More From InvestorPlace</h3>
		<ul><li>
						<a href="https://investorplace.com/2023/10/no-1-ai-investment-might-be-this-company-youve-never-heard-of/?cid=MKT764787&amp;eid=MKT771245">The #1 AI Investment Might Be This Company You&rsquo;ve Never Heard Of</a>
					</li>
																<li>
						<a href="https://investorplace.com/2023/07/elon-musks-project-omega-stuns-silicon-valley-insiders/?cid=MKT738510&amp;eid=MKT771236">Musk&rsquo;s &ldquo;Project Omega&rdquo; May Be Set to Mint New Millionaires. Here&rsquo;s How to Get In.</a>
					</li>
																<li>
						<a href="https://investorplace.com/2021/01/one-percenter-issues-urgent-warning/?cid=MKT499868&amp;eid=MKT793997">It doesn&rsquo;t matter if you have $500 or $5 million. Do this now.</a>
					</li>
									</ul><div>
			<div></div>
						<div></div>
					</div>
	The post <a href="https://investorplace.com/2024/04/todays-biggest-pre-market-stock-movers-10-top-gainers-and-losers-on-tuesday-april-2nd/">Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday</a> appeared first on <a href="https://investorplace.com">InvestorPlace</a>.

Today's Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday

Serina Therapeutics appoints Simba Gill as executive chairman

Serina Therapeutics files to sell 1.5M shares of common stock

AgeX Therapeutics GAAP EPS of -$3.38, revenue of $0.05M

Parkinson's-focused Serina Therapeutics, Enable Injections enter partnership

ACON

ACOR

AVTX

CMAX

GOEV

GRTS

GXAI

IMCC

LIFW

MVST

PPSI

TPET

VTSI

XTIA

ZPTA

Press Releases

Serina Therapeutics Announces Completion of Merger with AgeX Therapeutics

Serina Therapeutics Appoints Dr. Simba Gill as Executive Chairman

Serina Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Highlights

Health Care

Enable Injections and Serina Therapeutics Announce Agreement to Develop SER-252 in Combination with enFuse® for Advanced Parkinson's Disease

								Get Alert
SER	Serina Therapeutics, Inc.	05/09/2024	—	—	4,139	2,284	1.81	Get Alert
SER	Serina Therapeutics, Inc.	04/24/2024	—	—	5,469	2,602	2.1	Get Alert
SER	Serina Therapeutics, Inc.	04/09/2024	—	—	4,320	16,494	1	Get Alert

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Serina Therapeutics Stock (AMEX:SER), Short Interest Report

People Also Watch